Journal of clinical periodontology · 2026
Efficacy of Adjunctive Agents in the Management of Biofilm-Induced Gingivitis: A Systematic Review and Meta-Analysis.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Figuero Elena, Marruganti Crystal, Ambrosio Nagore, Izzetti Rossana, Serrano Jorge, Graziani Filippo
Аннотация
AIM: In systemically healthy humans with gingivitis, what is the efficacy of active agents compared to negative control/placebo when used adjunctively to mechanical biofilm control in terms of changes in gingivitis/bleeding indices and/or disease resolution in randomised controlled clinical trials (RCTs) with at least 3-months follow-up?
MATERIAL AND METHODS: Electronic searches, study selection, data extraction, risk of bias analysis, meta-analyses and certainty of the evidence were performed (GRADE).
RESULTS: Seventy-two RCTs were included (antiseptics n = 71; systemic intake n = 1). High heterogeneity was found in the definition of gingivitis. Antiseptic agents showed greater reductions in bleeding (%) than control groups at 3 months (ncomparison [nc] = 19; weighted mean differences [WMD] = 10.66%; p < 0.001) and 6 months (nc = 20; WMD = 10.79%; p < 0.001). Gingivitis resolution was rarely determined. Prevalence of local adverse effect (tooth-related and soft-tissue-related) varied from 0% to 13.1%. Systemic effects were scarcely evaluated.
CONCLUSIONS: In adults with gingivitis, the adjunctive use of specific antiseptics determined higher reduction of gingival inflammation at 3 months (moderate evidence for stannous fluoride and low-to-very low for chlorhexidine, essential oils or cetylpyridinium chloride [CPC]) and 6 months (moderate for chlorhexidine, low for CPC and very low for essential oils) over placebo/negative controls. Adverse effects are neither frequently nor extensively reported. Gingivitis resolution is rarely reported and achieved.
MATERIAL AND METHODS: Electronic searches, study selection, data extraction, risk of bias analysis, meta-analyses and certainty of the evidence were performed (GRADE).
RESULTS: Seventy-two RCTs were included (antiseptics n = 71; systemic intake n = 1). High heterogeneity was found in the definition of gingivitis. Antiseptic agents showed greater reductions in bleeding (%) than control groups at 3 months (ncomparison [nc] = 19; weighted mean differences [WMD] = 10.66%; p < 0.001) and 6 months (nc = 20; WMD = 10.79%; p < 0.001). Gingivitis resolution was rarely determined. Prevalence of local adverse effect (tooth-related and soft-tissue-related) varied from 0% to 13.1%. Systemic effects were scarcely evaluated.
CONCLUSIONS: In adults with gingivitis, the adjunctive use of specific antiseptics determined higher reduction of gingival inflammation at 3 months (moderate evidence for stannous fluoride and low-to-very low for chlorhexidine, essential oils or cetylpyridinium chloride [CPC]) and 6 months (moderate for chlorhexidine, low for CPC and very low for essential oils) over placebo/negative controls. Adverse effects are neither frequently nor extensively reported. Gingivitis resolution is rarely reported and achieved.